Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venetoclax, Cladribine, and Cytarabine in R/R AML
NCT05657639Phase 2Recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Oct 2022
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of venetoclax in acute myeloid leukemia (AML), sponsored by First Affiliated Hospital of Soochow University. Started Oct 2022; status: recruiting.
02
Drugs
venetoclax
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT05657639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05657639.